Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study

Abstract Background The objective of this study was to investigate the relation of severe COVID-19 to prior drug prescribing. Methods Severe cases were defined by entry to critical care or fatal outcome. For this matched case-control study (REACT-SCOT), all 4251 cases of severe COVID-19 in Scotland...

Full description

Bibliographic Details
Main Authors: Paul M. McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, Stuart J. McGurnaghan, David McAllister, Chris Robertson, Rachael Wood, Nazir Lone, Janet Murray, Thomas M. Caparrotta, Alison Smith-Palmer, David Goldberg, Jim McMenamin, Bruce Guthrie, Sharon Hutchinson, Helen M. Colhoun, on behalf of Public Health Scotland COVID-19 Health Protection Study Group
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Medicine
Subjects:
COVID-19
Pharmacoepidemiology
Antipsychotic agents
Opioids
Gabapentinoids
Proton pump inhibitors
Online Access:https://doi.org/10.1186/s12916-021-01907-8

Internet

https://doi.org/10.1186/s12916-021-01907-8

Similar Items